Literature DB >> 15905717

Optical imaging of spontaneous breast tumors using protease sensing 'smart' optical probes.

Christoph Bremer1, Vasilis Ntziachristos, Benedikt Weitkamp, Gregor Theilmeier, Walter Heindel, Ralph Weissleder.   

Abstract

OBJECTIVE: The objective of this study was to determine if spontaneous breast cancer lesions can be detected by fluorescence reflectance imaging (FRI) and fluorescence mediated tomography (FMT) using protease-sensing optical probes.
MATERIALS AND METHODS: Transgenic (FVB/N-TgN (WapHRAS)69Lin Y)) mice, which spontaneously develop breast cancer, were injected intravenously with a cathepsin-sensing fluorescent imaging probe. FRI and FMT were performed 24 hours after probe injection and region of interest (ROI) analysis was performed. Magnetic resonance images were acquired for anatomic coregistration with the FMT data. Moreover, correlative immunohistochemistry and fluorescence microscopy were performed.
RESULTS: All tumor nodules were clearly delineated by FRI showing an average signal intensity of 380 +/- 106 AU. Similarly, tumors were clearly detected by FMT imaging. Immunohistochemistry confirmed cathepsin-B expression of primary tumors and fluorescence microscopy revealed a strong Cy 5.5 deposition in the tissue.
CONCLUSIONS: FRI and FMT using "smart" protease sensing probes permits detection of experimental spontaneous breast cancers. Because the expression levels of various proteases correlate with patient outcome, this technique may not only help to detect, but also to differentiate breast cancers noninvasively.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15905717     DOI: 10.1097/01.rli.0000163797.23172.90

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  27 in total

1.  [Functional and molecular imaging of breast tumors].

Authors:  K Pinker; P Brader; G Karanikas; K El-Rabadi; W Bogner; S Gruber; M Reisegger; S Trattnig; T H Helbich
Journal:  Radiologe       Date:  2010-11       Impact factor: 0.635

2.  Molecular Imaging of Proteases in Cancer.

Authors:  Yunan Yang; Hao Hong; Yin Zhang; Weibo Cai
Journal:  Cancer Growth Metastasis       Date:  2009-08-17

Review 3.  In vivo imaging in cancer.

Authors:  John Condeelis; Ralph Weissleder
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-09-22       Impact factor: 10.005

4.  Three-dimensional fluorescence-enhanced optical tomography using a hand-held probe based imaging system.

Authors:  Jiajia Ge; Banghe Zhu; Steven Regalado; Anuradha Godavarty
Journal:  Med Phys       Date:  2008-07       Impact factor: 4.071

5.  Substrate-based near-infrared imaging sensors enable fluorescence lifetime contrast via built-in dynamic fluorescence quenching elements.

Authors:  Anand T N Kumar; William L Rice; Jessica C López; Suresh Gupta; Craig J Goergen; Alexei A Bogdanov
Journal:  ACS Sens       Date:  2016-02-09       Impact factor: 7.711

Review 6.  Tailoring Adjuvant Radiation Therapy by Intraoperative Imaging to Detect Residual Cancer.

Authors:  Melodi J Whitley; Ralph Weissleder; David G Kirsch
Journal:  Semin Radiat Oncol       Date:  2015-05-14       Impact factor: 5.934

7.  Combined fluorescence and X-Ray tomography for quantitative in vivo detection of fluorophore.

Authors:  W C Barber; Y Lin; O Nalcioglu; J S Iwanczyk; N E Hartsough; G Gulsen
Journal:  Technol Cancer Res Treat       Date:  2010-02

8.  Detection of in situ mammary cancer in a transgenic mouse model: in vitro and in vivo MRI studies demonstrate histopathologic correlation.

Authors:  S A Jansen; S D Conzen; X Fan; T Krausz; M Zamora; S Foxley; J River; G M Newstead; G S Karczmar
Journal:  Phys Med Biol       Date:  2008-09-09       Impact factor: 3.609

Review 9.  Obtaining adequate surgical margins in breast-conserving therapy for patients with early-stage breast cancer: current modalities and future directions.

Authors:  Rick G Pleijhuis; Maurits Graafland; Jakob de Vries; Joost Bart; Johannes S de Jong; Gooitzen M van Dam
Journal:  Ann Surg Oncol       Date:  2009-07-17       Impact factor: 5.344

10.  A novel fluorescent imaging agent for diffuse optical tomography of the breast: first clinical experience in patients.

Authors:  Stephanie van de Ven; Andrea Wiethoff; Tim Nielsen; Bernhard Brendel; Marjolein van der Voort; Rami Nachabe; Martin Van der Mark; Michiel Van Beek; Leon Bakker; Lueder Fels; Sjoerd Elias; Peter Luijten; Willem Mali
Journal:  Mol Imaging Biol       Date:  2009-10-02       Impact factor: 3.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.